- Category
- Micro (2020-21)
- Udyam number
- UDYAM-HR-05-0006278

Restogal Pharmaceuticals Private Limited
About Restogal Pharmaceuticals Private Limited
Data last updated:
Restogal Pharmaceuticals Private Limited is a private limited company based in Gurugram, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 31 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110HR2020PTC088847. Its GSTIN is 10AAKCR3957Q1ZT (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhola Rai and Shilpa Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – Nitin Jain Plot No – 190 Sector – 7 Imt – Manesar, Gurugram, Haryana, India – 122052.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.16 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹2.49 Lakh (net margin -115.7%) and EBITDA of -₹2.35 Lakh (EBITDA margin -109.1%).
Restogal Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0006278).
Company details
Recognitions & Rankings of Restogal Pharmaceuticals
Contact details
Restogal Pharmaceuticals Private Limited's registered office is in Gurugram, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressC/O – Nitin Jain Plot No – 190 Sector – 7 Imt – Manesar, Gurugram, Haryana, India – 122052
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
To see the full contact details of Restogal Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Restogal Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Restogal Pharmaceuticals Private Limited, buy the company report.
Financials of Restogal Pharmaceuticals Private Limited
FY 2025 filings availableRestogal Pharmaceuticals Private Limited reported revenue of ₹2.16 Lakh (down 68% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 68% in the latest year. EBITDA fell 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2.35 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2.49 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -109.1% | |||
| Net Profit Margin | -115.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Restogal Pharmaceuticals Private Limited, buy the company report.
Board of directors of Restogal Pharmaceuticals Private Limited
Restogal Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhola Rai | Director | 31 Aug 2020 | 6 Years 2 Months | Current |
| Shilpa Kumari | Director | 31 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Restogal Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dermatrait Pharmaceuticals Private Limited | ₹2.17 Lakh (FY 2025) | -7.0% | Delhi, India | |||
| Restogal Pharmaceuticals Private Limitedthis company | ₹2.16 Lakh (FY 2024) | -₹2.49 Lakh | -115.7% | -68.0% | Gurugram, Haryana, India | |
| Tasha Pharmaceuticals Private Limited | ₹2.12 Lakh (FY 2021) | -67.0% | Patna, Bihar, India | |||
| Medigenium Pharmaceuticals Private Limited | ₹2.11 Lakh (FY 2025) | -88.0% | Patna, Bihar, India | |||
| Capitis Pharmaceuticals Private Limited | ₹2.1 Lakh (FY 2022) | -39.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Restogal Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Restogal Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Restogal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Restogal Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAKCR3957Q1ZT | Bihar | Active | 03 Nov 2020 |
To see the full GST registrations and return filing status of Restogal Pharmaceuticals Private Limited, buy the company report.
Recent activity
Restogal Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Bhola Rai was appointed as Director on 31 Aug 2020.
Frequently asked questions
Restogal Pharmaceuticals is an active private limited company based in Gurugram, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 31 August 2020 (6+ years old) and is registered under CIN U24110HR2020PTC088847.
Restogal Pharmaceuticals has 2 current directors:
- Bhola Rai - Director
- Shilpa Kumari - Director
The latest financial statements of Restogal Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Restogal Pharmaceuticals is 10AAKCR3957Q1ZT, registered in Bihar.
The CIN (Corporate Identification Number) of Restogal Pharmaceuticals is U24110HR2020PTC088847. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Restogal Pharmaceuticals was incorporated on 31 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Restogal Pharmaceuticals by revenue are Dermatrait Pharmaceuticals Private Limited, Tasha Pharmaceuticals Private Limited, Medigenium Pharmaceuticals Private Limited, Capitis Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Bhola Rai was appointed as Director on 31 Aug 2020. Shilpa Kumari was appointed as Director on 31 Aug 2020.
Yes, Restogal Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0006278).
The registered office of Restogal Pharmaceuticals is at CO – Nitin Jain Plot No – 190 Sector – 7 Imt – Manesar, Gurugram, Haryana, India – 122052.
Restogal Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

